AstraZeneca Pharma India Limited has announced the resignations of two senior management personnel. Ms. Aditi Mehta, Business Unit Director – Oncology Business Unit, will depart on June 12, 2026, and Mr. Srikanth B.S., Site Lead, India Operations, will leave on June 15, 2026. Both individuals are pursuing career opportunities outside the organization. The company is actively seeking suitable replacements for these key roles.
Resignations of Senior Management
AstraZeneca Pharma India Limited has officially communicated the departures of two key senior management members. Ms. Aditi Mehta, who holds the position of Business Unit Director for the Oncology Business Unit, has decided to pursue career opportunities elsewhere. Her last day of employment with the company will be the close of business hours on June 12, 2026, after completing her handover period.
Further Departures and Succession Planning
Adding to the management changes, Mr. Srikanth B.S., serving as Site Lead for India Operations, has also announced his resignation. Mr. Srikanth’s departure is scheduled for the close of business hours on June 15, 2026, as he too will be exploring new career paths outside of AstraZeneca. The company has confirmed that it is in the process of identifying and recruiting suitable replacements to fill these critical positions and ensure continuity of operations.
Company’s Best Wishes
AstraZeneca Pharma India Limited has extended its best wishes to both Ms. Mehta and Mr. Srikanth for their future endeavors. The company acknowledges their contributions during their tenure and wishes them success in their subsequent professional journeys.
Source: BSE
